Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
不同环境下宫颈癌筛查流程的多层次优化
基本信息
- 批准号:10600841
- 负责人:
- 金额:$ 98.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-10 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAffectBayesian MethodCancer Control ResearchCaringCervicalCervical Cancer ScreeningCessation of lifeClinicClinicalCollaborationsColposcopyCommunity HealthcareComplexCountyDataData SourcesDetectionDevelopmentDiagnosticDisparityEffectivenessElectronicsEligibility DeterminationEpidemiologistEthnic OriginEvaluationExhibitsFailureGeographyGoalsGuidelinesHIVHIV InfectionsHarm ReductionHealthHealth systemHealthcareHealthcare SystemsHigh-Risk CancerHospitalsHuman Papilloma Virus VaccineHuman PapillomavirusInformation SystemsInterventionKnowledgeLaboratoriesLeadLeadershipLesionLow incomeMalignant neoplasm of cervix uteriManaged CareMassachusettsMeasuresMethodsModelingObservational StudyOncogenicOrganOutcomePatientsPhysiciansPoliciesPopulationPopulation HeterogeneityPreventionPrevention strategyProcessProviderRaceResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesRiskRisk AssessmentScientistScreening for cancerService delivery modelSubgroupSystemTechnologyTestingTexasTherapeutic immunosuppressionTimeUninsuredVariantVulnerable PopulationsWashingtonWomancancer invasivenesscancer typecare systemscervical cancer preventionclinical practicecohortcolorectal cancer screeningcommunity settingdesigndisparity reductionethnic minorityexperiencefollow-uphealth care deliveryhealth care settingsimprovedinnovationlung cancer screeningmedical specialtiesmultidisciplinarymultilevel analysisnew technologynovelpatient populationpaymentpersonalized screeningpremalignantprimary care providerprogramsprovider networksracial minoritysafety netscreeningscreening guidelinessocioeconomicstooluptake
项目摘要
ABSTRACT
For more than 5 decades, the US has sought to lower cervical cancer deaths through screening; however,
disparities remain. Introduction of oncogenic human papillomavirus (HPV)-based tests and HPV vaccines have
expanded cervical cancer prevention strategies and changed screening and management guidelines. As
technology, guidelines, and policies change, our MultilEvel OpTimization of the CeRvIcal Cancer Screening
Process in Diverse Settings & Populations (METRICS) PROSPR II Research Center will elucidate multilevel
factors that hamper or facilitate the cervical cancer screening process and reduce disparities in vulnerable
populations. METRICS unites three PROSPR I Research Centers with demonstrated capability to provide
validated data for a combined cohort of ~1.2 million screened and unscreened women. Our community
settings represent 3 care delivery models—safety-net system, managed care system, and primary care
provider networks in Texas, Washington, and Massachusetts. We will collect, harmonize, and document >
10 years of high-quality, comprehensive cervical cancer screening process data at the patient, provider,
clinic, and system levels using a rich array of electronic clinical information systems and novel data sources.
Our combined cohort is socioeconomically and geographically diverse and includes vulnerable groups
such as HIV-infected and uninsured women. Our three interconnected observational projects are
designed to understand how cervical cancer screening is delivered across our spectrum of delivery models,
and how to optimize the screening process to reduce disparities. Innovative geospatial and Bayesian statistical
methods in Project 1 will better elucidate at what levels variation in screening process occurs. Project 2 will
investigate how multilevel programs and policies influence adherence to guidelines for average-risk women.
Project 3 will inform precision screening for women with altered risk. Based on our observational findings, in
years 4-5, we will design and implement pilot interventions leveraging IT-enabled tools to address key failures
in the screening process and reduce disparities. Our transdisciplinary team has epidemiologists, primary and
specialty care physicians, and intervention, implementation, and healthcare delivery experts. We are poised to
efficiently evaluate the full cervical cancer screening process and provide expertise, leadership, and resources
for cross-organ PROSPR II collaborations. Our cores and research projects will achieve our goals of
advancing understanding of screening as practiced in community settings through: (1) analysis of
multilevel observational data from our heterogeneous settings with diverse populations, (2) development and
testing of impactful interventions to optimize the screening process, and (3) application of our novel
observational projects and quality metrics to the cancer screening processes for other organs. Based on our
successful experience leading and collaborating in PROSPR I, we thoughtfully organized our four cores to
be able to launch research activities and contribute to trans-PROSPR II activities quickly and effectively.
抽象的
在过去的50多年中,美国试图通过筛查降低癌症的死亡。
差异仍然存在。
扩大了宫颈癌的预防策略,并改变了屏幕和管理指南
技术,准则和政策变化,我们对宫颈癌筛查的多级优化
各种环境与人口(指标)PROSPR II研究中心的过程将阐明多级
阻碍或促进宫颈癌筛查过程并减少脆弱性差异的因素
人群。
验证了约120万筛查和未经筛查的妇女的总组合
设置代表3种护理交付模型 - 安全网络系统,托管护理系统和初级护理
德克萨斯州,华盛顿和马萨诸塞州的提供者网络。
10年的高质量,全面的宫颈癌筛查过程数据,提供者,提供者,
诊所和系统水平使用丰富的电子临床信息系统和新型数据源。
我们的组合队列在社会经济和地理上多样化,包括脆弱的群体
例如感染HIV的妇女。
旨在了解宫颈癌筛查的递送模型如何交付
以及如何优化筛选过程以减少差异。
项目1中的方法将在筛选过程中更好地阐明项目2
调查多级计划和政策如何影响普通风险妇女的准则。
项目3将根据我们的观察发现,以改变风险。
4 - 5年,我们将设计和实施Pilot Pilot Pilot IT支持IT的工具工具工具工具工具关键故障
在筛选过程中,我们的跨学科团队具有流行病学家
我们准备好拥有专业护理护理护理医生以及国际,实施和医疗保健服务专家。
有效评估完整的宫颈癌筛查过程,并提供专业知识,领导和资源
对于跨器官II合作,我们的核心和研究项目将实现我们的目标
通过:(1)分析社区环境中对筛查的理解
来自不同人群的异质环境中的多级观察数据,(2)开发和
测试有影响力的干预剂以优化筛选过程,以及(3)应用我们的小说
基于我们的其他器官的癌症筛查过程的观察项目和质量指标
在ProSpri领导和合作的成功经验
能够启动研究活动并为Trans-Prospr II活动做出迅速有效的贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Chubak其他文献
Jessica Chubak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Chubak', 18)}}的其他基金
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
- 批准号:
10658891 - 财政年份:2020
- 资助金额:
$ 98.66万 - 项目类别:
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
- 批准号:
10477003 - 财政年份:2020
- 资助金额:
$ 98.66万 - 项目类别:
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
- 批准号:
10263878 - 财政年份:2020
- 资助金额:
$ 98.66万 - 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
- 批准号:
10428568 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
- 批准号:
10601364 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
- 批准号:
10202500 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
Psychological benefits and potential pathogen transmission in hospitalized pediatric oncology patients receiving therapy dog visits: a randomized controlled trial
接受治疗犬就诊的住院儿科肿瘤患者的心理益处和潜在病原体传播:一项随机对照试验
- 批准号:
9322093 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
相似国自然基金
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
- 批准号:72162025
- 批准年份:2021
- 资助金额:29 万元
- 项目类别:地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
科学基金应如何在国家创新体系中更好地坚持定位并充分发挥独特作用
- 批准号:
- 批准年份:2019
- 资助金额:60 万元
- 项目类别:专项基金项目
企业坚持做慈善吗:企业持续捐赠特征及其成因与经济后果研究
- 批准号:71402044
- 批准年份:2014
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别:
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
- 批准号:
10696409 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别:
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:
10643145 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别:
Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis
活动和小睡:在锻炼计划中添加失眠治疗,以改善患有膝骨关节炎的老年人的疼痛结果
- 批准号:
10797056 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别:
Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study)
项目:旨在改善前列腺癌幸存者 HRQoL 差异的生存护理体力活动计划(RELate 研究)
- 批准号:
10911646 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别: